Email

eric.rohren@bcm.edu

Positions

Professor and Chair

Radiology
Baylor College of Medicine
Houston, TX US

Interim Chair

Radiation Oncology
Baylor College of Medicine
Houston, TX USA

Addresses

BCM-MD Anderson Hall (Office)

Room: BCMA-165
Houston, TX 77030
United States
Phone: (713) 798-4417
rohren@bcm.edu

Education

MD-PhD from Mayo Clinic

06/1996 - Rochester, Minnesota United States

Internship at Mayo Clinic

06/1997 - Rochester, Minnesota United States

Residency at Duke University

06/2001 - Durham, North Carolina United States

Diagnostic Radiology

Fellowship at Duke University

06/2002 - Durham, North Carolina United States

Nuclear Medicine

Certifications

Board certified

American Board of Radiology, 2001

Board certified

American Board of Nuclear Medicine, 2009

Professional Interests

• Complimentary roles of functional and anatomic imaging in the assessment of malignancy
• Novel radiopharmaceuticals for the imaging of cancer
• Emerging applications of PET/MR
• Molecular brain imaging for evaluation of neurocognitive disorders

Professional Statement

Dr. Rohren is Chair of the Department of Radiology which is comprised of over 120 faculty members and spans multiple systems including CHI Baylor St. Luke's Medical Center, Ben Taub Hospital and Harris Health System, the Michael E. DeBakey VA Medical Center, and Texas Children's Hospital.
He has served on numerous boards and committees in the Nuclear Medicine field, including the SNMMI's PET Center of Excellence and the American College of Radiology's Commission on Nuclear Medicine. He was on the Board of Directors of the American Board of Nuclear Medicine, serving as Chair of the Board from 2013-2014.
Dr. Rohren is a recognized expert in PET imaging (with over 100 peer reviewed publications), and speaks nationally and internationally (over 100 invited presentations/lectures/visiting professorships) on diagnostic and therapeutic nuclear medicine, particularly clinical applications of PET/CT in the oncology patient population.

Websites

Selected Publications

• Hurwitz M, Buscombe JR, Jacene HA, Klitzke AK, Lamonica D, Lu Y, Pryma DA, Rohren EM, et al. "ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy with Radium-223." Am J Clin Oncol. 2020 Jun 9;doi: 10.1097/COC.0000000000000702(Online ahead of print.) Pubmed PMID: 32520788
• Currie G, Hawk KE, Rohren EM "Ethical principles for the application of artificial intelligence (AI) in nuclear medicine.." Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):748-752. Pubmed PMID: 31927637
• Ailawadhi S, Sexton R, Lentzsch S, Abidi MH, Voorhees PM, Cohen AD, Rohen EM, et al. "Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma." Clin Cancer Res. 2020 Apr 16;doi. 10.1158/1078-0432.CCR-19-1997.(Online ahead of print.) Pubmed PMID: 32299820
• Currie G, Hawk KE, Rohren EM, et al. "Machine Learning and Deep Learning in Medical Imaging: Intelligent Imaging." J Med Imaging Radiat Sci. 2019 Dec;50(4):477-487. Pubmed PMID: 31601480

Memberships

American College of Radiology

Member (01/2009)

American College of Radiology

Member, Commission on Nuclear Medicine (07/2011)

American College of Physician Executives

Member (07/2012)

American College of Surgeons - Commission on Cancer

Member, Quality Integration Committee (01/2012)

American College of Surgeons - Commission on Cancer

Member, Alliance/ACS CRP Cancer Care Deliver Research Committee (01/2012)

American Roentgen Ray Society

Member (01/1997)

American Roentgen Ray Society

Member, ARRS Corporate Relations Committee (01/2016)

Radiological Society of North America

Member (01/1997)

Society of Nuclear Medicine and Molecular Imaging

Member (01/2002)

Southwest Oncology Group

Member, Imaging Subcommittee (06/2012)

Southwest Oncology Group

Member, Myeloma Working Group (06/2012)

Funding

Co-Investigator - #Trial S1304

(07/19/2013 Southwest Oncology Group

Carfilzomib and Dexamethasone for Treating Patients with Relapsed or Refractory Myeloma